Events und Webinare

ISPOR Europe 2024

17-20 November 2024 Barcelona, Spanien

Meet Fortrea’s Market Access Consulting & HEOR team at ISPOR Europe 2024

Meet us in Barcelona, Spain from November 17-20 as we take part in the leading European conference for health economics and outcomes research (HEOR). While at ISPOR Europe 2024, we invite you to meet with our team of Market Access Consulting & HEOR professionals who will be on hand to discuss the key challenges you are facing in market access, pricing and health economics. With Fortrea's market access and HEOR expertise, we identify evidence gaps and design and execute custom projects to support your product and stakeholder needs. Rely on us to help ensure you are equipped to demonstrate the full value of your product across the audiences of regulators, providers, payers, policymakers and patients.

Stop by any one of the six posters Fortrea is presenting and connect with our subject matter experts presenting them, as well as Gordon Cummins, Senior Director, Global Growth Lead, Fortrea Market Access Consulting & HEOR, who will be attending.

Gordon Cummins

Senior Director, Global Growth Lead, Fortrea Market Access Consulting & HEOR

Featured presentations

18 Nov | 16:00 - 19:00

Use of External Control Arms in Reimbursement Submissions: A Review of CAR-T Appraisals by NICE and CDA

Comentale S¹2, Messina P¹, Daniel S³, Jin G², Szende A² ¹Fortrea, Milan, Italy, ²Fortrea, Maidenhead, UK, ³Fortrea, Tel Aviv, Israel

Poster Session 2

S Comentale

18 Nov | 16:00 - 19:00

Emerging Trends in the Adoption of Alternative Financing Models for Advanced Therapy Medicinal Products: A Scoping Review

Cardoso A¹, Wallace M² ¹Fortrea, Lisbon, Portugal, ¹Fortrea, Maidenhead, UK

Poster Session 2

A Cardoso

M Wallace

19 Nov | 10:30 - 13:30

Socioeconomic Indicators of Self-Reported Health Based on EQ-5D-5L: Results From General Population Surveys in England and Spain

Szende A¹, Feng YS², Janssen MF³ ¹Fortrea, York, North Yorkshire, UK, ²Medical University of Tübingen, Tübingen, Baden-Württemberg, Germany, ³The EuroQol Group, Rotterdam, Rotterdam, Netherlands

Poster Session 3

A Szende

19 Nov | 10:30 - 13:30

Setting Diversity Enrollment Goals in Clinical Trials Based on Real-World Data: Potential Challenges With Multi-Country Requirements

Plante K¹, Kiri V², Knight T³, Howell A⁴ ¹Fortrea Inc., Gaithersburg, MD, USA, ²Fortrea Inc., Guildford, SRY, UK, ³Fortrea Inc., Princeton, NJ, USA, ⁴Fortrea Inc., London, London, UK

Poster Session 3

K Plante

19 Nov | 16:00 - 19:00

Use of Secondary Real-World Data From the United States to Fulfill European Medicines Agency Post Authorization Requirement

Knight T¹, Plante K², Ruggieri A³ ¹Fortrea Inc., Greenwood, IN, USA, ²Fortrea Inc., Guildford, SRY, UK, ³Angelini Pharma S.p.A, Rome, Italy

Poster Session 4

K Plante

19 Nov | 16:00 - 19:00

A Framework for Assessing the Viability of an Externally Controlled Arm for a Single-Arm Trial

Kiri V¹, Anastassopoulos KP² ¹Fortrea Inc., Guildford, SRY, UK, ²Fortrea, Inc., Gaithersburg, MD, USA

Poster Session 4

K Plante (Anastassopoulos)